Back to Search
DONNA PERLIN, MD
MD
Pediatric Emergency Medicine (Emergency Medicine) Physician
NPI: 1700829694Individual
Specialties, Licenses & Credentials
Pediatric Emergency Medicine (Emergency Medicine) PhysicianPrimary
Emergency Medicine — Pediatric Emergency Medicine
Code: 207PP0204X
MD41640(TN)
Research & Publications (20)
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
PMID 19546367·Antimicrob Agents Chemother·2009
8-other
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
PMID 19104024·Antimicrob Agents Chemother·2009
7-preclinical
Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge.
PMID 19124600·Infect Immun·2009
7-preclinical
Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints.
PMID 18955538·Antimicrob Agents Chemother·2009
8-other
Rapid real-time nucleic Acid sequence-based amplification-molecular beacon platform to detect fungal and bacterial bloodstream infections.
PMID 19403758·J Clin Microbiol·2009
8-other
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.
PMID 19624922·Emerg Infect Dis·2009
8-other
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
PMID 18794386·Antimicrob Agents Chemother·2008
5-case
Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure.
PMID 18500928·J Infect Dis·2008
8-other
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
PMID 18378714·Antimicrob Agents Chemother·2008
5-case
Rapid detection of triazole antifungal resistance in Aspergillus fumigatus.
PMID 18234874·J Clin Microbiol·2008
8-other
Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.
PMID 18794385·Antimicrob Agents Chemother·2008
4-observational
Clinical characterization of human metapneumovirus infection among patients with cancer.
PMID 19027169·J Infect·2008
8-other
A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.
PMID 18443110·Antimicrob Agents Chemother·2008
4-observational
Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection.
PMID 18832004·Vaccine·2008
7-preclinical
Calcineurin target CrzA regulates conidial germination, hyphal growth, and pathogenesis of Aspergillus fumigatus.
PMID 18456861·Eukaryot Cell·2008
7-preclinical
Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.
PMID 18644959·Antimicrob Agents Chemother·2008
4-observational
Serum differentially alters the antifungal properties of echinocandin drugs.
PMID 17420211·Antimicrob Agents Chemother·2007
7-preclinical
Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase.
PMID 17325225·Antimicrob Agents Chemother·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3601 TVC
NASHVILLE, TN 37232 - Phone
- (615) 322-3000
Quick Facts
- NPI
- 1700829694
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile